Published in Pharmaceuticals by Sikiric and colleagues, the comprehensive review synthesizes decades of preclinical research demonstrating BPC-157s remarkable ability to modulate dopaminergic, serotonergic, glutamatergic, GABAergic, and nitric oxide systems simultaneously
Current evidence suggests that risk correlates more with the magnitude of weight loss than with a specific agent
Because it has multiple targets, DPP-4i would be a good choice with which to treat hypertension, especially in patients with chronic inflammatory diseases, such as coronary heart disease, diabetes mellitus, and hyperlipidemia
What Is Bioperine Used for
GIP also stimulates glucagon secretion to prevent hypoglycemic conditions (Cai et al